← Back to Glossary
Q

Quality Risk Management

Biopharmaceutical Glossary

Quality Risk Management constitutes a systematic process for assessing, controlling, communicating, and reviewing risks to product quality throughout the lifecycle, enabling science-based and proactive decision-making supporting better quality outcomes. This disciplined approach, described in ICH Q9 guidance, employs established risk management tools identifying what might go wrong, evaluating likelihood and consequences, prioritising risks, and implementing appropriate controls or mitigation strategies.

The pharmaceutical industry applies quality risk management throughout development, manufacturing, and distribution. Common applications include process development identifying critical process parameters requiring control, validation determining extent based on risk assessment, change control evaluating potential impacts, deviation investigation assessing product impact, supplier qualification prioritising audit frequency, and continuous improvement focusing resources on highest risks. Risk management tools include Failure Mode and Effects Analysis, Hazard Analysis and Critical Control Points, risk ranking and filtering, and fault tree analysis. Documentation captures risk assessment basis, decisions made, and rationale. Regulatory inspections examine risk management implementation, documentation, and effectiveness. As complexity increases and regulatory frameworks emphasise risk-based approaches, quality risk management continues as an essential tool enabling rational, proactive quality decisions optimising resource allocation and ensuring patient protection.

← Back to Glossary
WhatsApp WeChat